[Parameningeal cervical rhabdomyosarcoma in the neonatal period].
A case of parameningeal cervical rhabdomyosarcoma with severe bone destruction is reported in a 3 month-old infant; symptoms were present at birth. The treatment consisted of exclusive intensive chemotherapy. The outcome was favourable with complete tumor regression and vertebral bone reconstruction. The child was on complete remission without sequellae two years later.
Plantaz
D
D
Médecine infantile A, CHU de Grenoble, France.
Bachelot
C
C
Dyon
J F
JF
Pasquier
D
D
Baudain
P
P
Durand
C
C
Bost
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D005260:Female; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007069:Ifosfamide / Q000627:therapeutic use; D007223:Infant; D008279:Magnetic Resonance Imaging; D011859:Radiography; D012208:Rhabdomyosarcoma / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D014750:Vincristine / Q000627:therapeutic use
D003609:Dactinomycin; D014750:Vincristine; D007069:Ifosfamide
Rhabdomyosarcome cervival paraméningé en période néonatale.